Publication | Closed Access
Azithromycin for the secondary prevention of coronary heart disease events. The WIZARD study: a randomized controlled trial
37
Citations
0
References
2004
Year
Preventive MedicineAntibioticsCardiovascular DiseaseWizard StudySecondary PreventionCardiovascular PharmacologyPharmacotherapyPreventive CardiologyMedicineCardiologyCoronary Artery Disease
No additional data available for this publication yet. Check back later!